Abstract
The COVID-19 pandemic in the US has been largely monitored on the basis of death certificates containing reference to COVID-19. However, prior analyses reveal that a significant percentage of excess deaths associated with the pandemic were not directly assigned to COVID-19 on death records. In the present study, we estimate a generalized linear model of expected mortality in 2020 based on historical trends in deaths by county of residence between 2011 and 2019. We use the results of the model to generate county estimates of excess mortality and excess deaths not assigned to COVID-19 for each county in the US. Overall, we estimate that 437,849 excess deaths occurred in 2020, among which 88% were assigned to COVID-19. The proportion assigned to COVID-19 was lower in the West (82%) and South (83%) as compared to counties in the Midwest (90%) and Northeast (97%). Urban counties (87%) reported lower proportions of excess deaths assigned to COVID-19 than rural areas (93%). The New England Census Division stood out as the only division where directly assigned COVID-19 deaths actually exceeded excess deaths, indicating that reductions in mortality from other causes of death may have occurred. Across individual counties, the percentage of excess deaths not assigned to COVID-19 varied substantially, with some counties’ direct COVID-19 tallies capturing only a small fraction of total excess deaths. Our findings suggest that consideration of excess deaths across counties is critical for a full accounting of geographic inequities in mortality during the pandemic.
Competing Interest Statement
ACS reported receiving grants from Ethicon Inc. and Swiss Re outside the submitted work. No other disclosures were reported.
Funding Statement
The Robert Wood Johnson Foundation supported the research reported in this publication (Grant #77521).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Boston University Medical Center Institutional Review Board
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* The authors would like to thank Robert N. Anderson and Farida B. Ahmad from the National Center for Health Statistics, Katherine Hempstead from the Robert Wood Johnson Foundation (RWJF), and Abe Dunn from the Bureau of Economic Analysis (BEA) for their input and technical support. Stokes gratefully acknowledges financial support from the RWJF. The views expressed in this paper are those of the authors and not necessarily the views of the BEA or RWJF.
Data Availability
The present investigation used publicly available data from the National Center for Health Statistics and the U.S. Census Bureau.
https://data.cdc.gov/NCHS/AH-County-of-Residence-COVID-19-Deaths-Counts-2020/75vb-d79q
